Personalized oral dosing plan with specific timing, frequency, and duration tailored to your cognitive needs, health status, and performance optimization objectives
And just as a reminder, the content in this podcast episode is no substitute for medical advice, diagnosis, or treatment from your medical or licensed health care team
In the SURMOUNT-1 trial, people treated with tirzepatide lost up to 22.5% of their body weight over 72 weeks , making it even more effective than semaglutide (NEJM tirzepatide study)
But not all delivery methods are created equal
They ensure safety standards and improve revenue prospects for approved pharmaceutical manufacturers
Advantage : Semaglutide Regulatory and Availability# CagriSema : Novo Nordisk filed for FDA approval in 2025 based on REDEFINE results